{"id":117023,"date":"2020-11-20T20:44:17","date_gmt":"2020-11-20T17:44:17","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/biofriendly-protocells-pump-up-blood-vessels\/"},"modified":"2020-11-20T20:44:17","modified_gmt":"2020-11-20T17:44:17","slug":"biofriendly-protocells-pump-up-blood-vessels","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/biofriendly-protocells-pump-up-blood-vessels\/","title":{"rendered":"#Biofriendly protocells pump up blood vessels"},"content":{"rendered":"

“#Biofriendly protocells pump up blood vessels<\/strong>”<\/p>\n

\n
\n
\n
\"Biofriendly
\n Enzyme-media<\/a>ted Nitric Oxide Production in Vasoactive Erythrocyte Membrane-enclosed Coacervate Protocells. Credit: Nature Chemistry (2020).
\n <\/figcaption><\/figure>\n<\/div>\n<\/div>\n

An international team comprising researchers from the University of Bristol, and Hunan and Central South Universities in China, have prepared biocompatible protocells that generate nitric oxide gas\u2014a known reagent for blood vessel dilation\u2014that when placed inside blood vessels expand the biological tissue.<\/p>\n


\n <\/section>\n

In a new study published today in Nature Chemistry<\/i>, Professor Stephen Mann and Dr. Mei Li from Bristol’s School of Chemistry, together with Associate Professor Jianbo Liu and colleagues at Hunan University and Central South University in China, prepared synthetic protocells coated in red blood cell fragments for use as nitric oxide generating bio-bots within blood vessels.<\/p>\n

Coating the protocells led to increased levels of biocompatibility and longer blood circulation times. Critically, the team trapp<\/a>ed an enzyme inside the protocells which, in the presence of glucose, produced hydrogen peroxide. This was then used by haemoglobin in the protocell membrane to degrade the drug molecule hydroxyurea into nitric oxide gas.<\/p>\n

When placed inside small pieces of blood vessels, or injected into a carotid artery, the protocells produced sufficient amounts of nitric oxide to initiate the biochemical pathways responsible for blood vessel vasodilation.<\/p>\n

Although at a very early stage of development, the new approach could have significant benefits in biomedicine, cellular diagnostics and bioengineering.<\/p>\n

Professor Stephen Mann, Co-Director of the Max Planck Bristol Centre for Minimal Biology at Bristol, said: “This work could open up a new horizon in protocell research because it highlights the opportunities for creating therapeutic, cell-like objects that can directly interface with living biological tissues.”<\/p>\n

Associate Professor Jianbo Liu at Hunan University added: “We are all really excited about our proof-of-concept studies but there is a lot of work still to be done before protocells can be used effectively as bio-bots in therapeutic applications. But the potential looks enormous.”<\/p>\n\n

\n

Enzyme-powered protocells rise to the top\n <\/p><\/div>\n

\n
\n More information:<\/strong>
\n Songyang Liu et al, Enzyme-mediated nitric oxide production in vasoactive erythrocyte membrane-enclosed coacervate protocells, Nature Chemistry<\/i> (2020). DOI: 10.1038\/s41557-020-00585-y<\/a><\/p><\/div>\n
\n Provided by
\n University of Bristol
\n
\n <\/svg><\/a><\/p><\/div>\n

<\/p>\n

\n

Citation<\/strong>:
\n Biofriendly protocells pump up blood vessels (2020, November 20)
\n retrieved 21 November 2020
\n from https:\/\/phys.org\/news<\/a>\/2020-11-biofriendly-protocells-blood-vessels.html<\/p>\n

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
\n part may be reproduced without the written permission. The content is provided for information purposes only.<\/p><\/div>\n<\/p><\/div>\n